×
Back to Agenda
Day 2: Session 4: RBM: The Site, CRO and Pharma Perspective
Session Chair(s)
Durga A. Gadgil
Clinical Research Consultant, India
Speaker(s)
Prasida Dinesh, RPh
Associate Director, Chiltern Clinical Research (I) Pvt. Ltd, India
Session 4.1: Establishing Operations in RBM: The CRO Perspective
Abhijit Arun Parab, MS
Director - CDM and Programming, Allergan, United States
Session 4.2: Allergan RBM Implementation: Strategy: A Case Study
Sauren Das
Country Head & Director - Operations, Excel Life Sciences Pvt. Ltd., India
Session 4.3: The Critical role of the CRC in transitioning to an RBM model
Have an account?